2020: A Significant Year for Drug Discovery and Us

Arctoris’ automated laboratory is based in Oxford, United Kingdom
Our CEO Martin-Immanuel Bittner reflects on 2020 and the opportunities ahead
Martin-Immanuel Bittner, MD DPhil is the CEO of Arctoris, the world’s first fully automated drug discovery platform that he co-founded in 2016.

About Arctoris Ltd

Arctoris Ltd is an Oxford-based research company that is revolutionising drug discovery for virtual and traditional biotechnology companies, pharmaceutical corporations and academia. Arctoris has established the world’s first fully automated drug discovery platform, offering pre-optimised and fully validated processes for its partners and customers globally. Accessible remotely, the platform provides on-demand access to a wide range of biochemical, cell biology and molecular biology assays conducted by robotics, enabling rapid, informed decision-making in basic biology, target validation, toxicology and phenotypic screening. These assay capabilities are accessed using a powerful online portal that streamlines experiment planning, ordering, tracking and data analysis. Thanks to the Arctoris platform, customers can rapidly, accurately and cost-effectively perform their research and advance their drug discovery programmes.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Arctoris Ltd

Arctoris Ltd

19 Followers

We are the world’s first fully automated R&D platform generating drug discovery data on demand www.arctoris.com